GlassScriptPhysician profile
Norma Barajas
NPI 1720210487
$1,798.85
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $978 · 2020: $84.29 · 2021: $419 · 2022: $318.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $644.82 | 2019-2021 | |
| Alcon Vision LLC | $323.83 | 2019-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $211.79 | 2019-2021 | |
| Sight Sciences, INC. | $149.76 | 2021 | |
| Sun Pharmaceutical Industries INC. | $122.55 | 2022 | |
| Bausch & Lomb Americas INC. | $108.63 | 2022 | |
| Shire North American Group INC | $88.17 | 2019 | |
| Topcon Healthcare, INC. | $85.48 | 2019 | |
| Coopervision INC. | $46.58 | 2019 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Norma Barajas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.